Post quarterly results, the consensus target on the scrip stays at Rs 2,881, similar to Rs 2,880 before earnings, with 80 per cent of recommendations suggesting a buy, 13 per cent hold and 7 per cent sell on the stock. The target suggests a potential 20 per cent upside for the stock.